Breaking News, Financial News

1Q Financial Reports: Cambrex

1Q Revenues: $119.8 million (+7%)

1Q Loss: $824,000 (net earnings of $4 million in 1Q2005)

Comments: Contract biopharma sales rose 79% to $13.8 million, but $5.2 million was due to shipping inventory from a Phase III project cancelled in 4Q2005.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters